Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Humana Inc. (NYSE: HUM) closed the day trading at $361.00 up 0.04% from the previous closing price of $360.87. In other words, the price has increased by $0.04 from its previous closing price. On the day, 1.05 million shares were traded. HUM stock price reached its highest trading level at $362.74 during the session, while it also had its lowest trading level at $357.51.
Ratios:
For a better understanding of HUM, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on April 02, 2024, Downgraded its rating to Neutral and sets its target price to $342 from $470 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 20 ’24 when Mesquita Jorge S. bought 545 shares for $367.09 per share. The transaction valued at 200,066 led to the insider holds 2,578 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 43500859392 and an Enterprise Value of 34494730240. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.47, and their Forward P/E ratio for the next fiscal year is 17.63. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 13.31. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40 while its Price-to-Book (P/B) ratio in mrq is 2.70. Its current Enterprise Value per Revenue stands at 0.316 whereas that against EBITDA is 7.713.
Stock Price History:
Over the past 52 weeks, HUM has reached a high of $530.54, while it has fallen to a 52-week low of $298.61. The 50-Day Moving Average of the stock is 8.77%, while the 200-Day Moving Average is calculated to be -13.80%.
Shares Statistics:
Over the past 3-months, HUM traded about 1.68M shares per day on average, while over the past 10 days, HUM traded about 1546950 shares per day. A total of 122.22M shares are outstanding, with a floating share count of 120.18M. Insiders hold about 0.27% of the company’s shares, while institutions hold 92.62% stake in the company. Shares short for HUM as of 1715731200 were 3641069 with a Short Ratio of 2.16, compared to 1713139200 on 3301007. Therefore, it implies a Short% of Shares Outstanding of 3641069 and a Short% of Float of 3.0299999.
Dividends & Splits
HUM’s forward annual dividend rate is 3.54, up from 3.54 a year ago. Against a Trailing Annual Dividend Yield of 0.009809627The stock’s 5-year Average Dividend Yield is 0.68.
